Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jun 05, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹9.74+0.62% 1 day change | -2.4% | ₹108 Crs |
Expense ratio | 0.66% as on May 31, 2025 |
Exit load | 0.5% Exit load of 0.50%, if redeemed within 90 days.! |
AUM (Fund size) | ₹108 Crs |
Lock-in | No Lockin |
Age | 6 m since Nov 19, 2024 |
Benchmark | BSE Healthcare TRI |
Min. investment | This scheme is currently not buyable |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year |
Period | This fund | Category average |
---|---|---|
1 Month | 2.2% | 2.88% |
3 Months | 8.34% | 7.74% |
Large Cap 34.562411%
Mid Cap 28.043353000000003%
Small Cap 32.433739%
Other Cap 0.009502999999991357%
Healthcare 85.47%
Services 4.52%
Insurance 2.86%
Chemicals 2.18%
Bifurcation by Credit Quality is not available for this fund
Others 4.54%
CBLO 4.54%
Net Receivables 0.42999999%
Others 0.43%
Fund name | ETM Rank | AUM (in Crs.) | Fund age | Expense ratio |
---|---|---|---|---|
PGIM India Healthcare Fund | N.A. | ₹108 Crs | 6 m | 0.66% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | ₹5,295 Crs | 6 yrs 11 m | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | ₹3,671 Crs | 12 yrs 5 m | 0.9% |
DSP Healthcare Fund | N.A. | ₹2,912 Crs | 6 yrs 6 m | 0.62% |
Tata India Pharma & HealthCare Fund | N.A. | ₹1,223 Crs | 9 yrs 6 m | 0.63% |
Nippon India Pharma Fund | N.A. | ₹8,260 Crs | 12 yrs 5 m | 0.89% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
PGIM India Healthcare Fund | 2.2% | N.A. | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.88% | -0.14% | 25.44% | 29.52% | 26.05% | 15.47% |
SBI Healthcare Opportunities Fund | -0.45% | -2.56% | 22.12% | 28.55% | 25.03% | 13.48% |
DSP Healthcare Fund | 3.23% | -8.17% | 18.58% | 25.97% | 24.77% | 15.31% |
Tata India Pharma & HealthCare Fund | 1.73% | -3.32% | 17.87% | 25.5% | 23.11% | 13.08% |
Nippon India Pharma Fund | 3.34% | -1.17% | 17.02% | 25.52% | 22.9% | 15.77% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
PGIM India Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.67 | 0.95 | 1.31 | 1.94 |
SBI Healthcare Opportunities Fund | 13.98 | 0.84 | 1.4 | 2.1 |
DSP Healthcare Fund | 15.15 | 0.86 | 1.14 | 1.95 |
Tata India Pharma & HealthCare Fund | 16.18 | 0.98 | 1.05 | 1.68 |
Nippon India Pharma Fund | 14.97 | 0.89 | 1.14 | 1.74 |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
Fund AUM | ₹108 Crs as on Mar 31, 2025 |
Scheme document | View Scheme Document |
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
No. of schemes | 24 view all schemes |
Total AUM | ₹24,165 Crs as on Mar 31, 2025 |
Address | 204, 2nd Floor, Jalaram Business Centre, Ganjawala Lane Near Chamunda Circle, Borivali (W) Mumbai, 400092 |
Phone | 022-61593000 / 1800-266-2667 |
Fund name | ETM Rank | AUM (in Crs.) | 1Y | 5Y |
---|---|---|---|---|
PGIM India Midcap Opportunities Fund | N.A. | ₹10,602 Crs | 10.25% | 31.27% |
PGIM India Flexi Cap Fund | N.A. | ₹6,143 Crs | 11.85% | 24.56% |
PGIM India ELSS Tax Saver Fund | N.A. | ₹764 Crs | 11.93% | 23.79% |
PGIM India Large Cap Fund | N.A. | ₹593 Crs | 9.08% | 19.42% |
PGIM India Global Equity Opportunities Fund | N.A. | ₹1,301 Crs | 5.16% | 12.57% |
PGIM India Small Cap Fund | N.A. | ₹1,399 Crs | 12.0% | N.A. |
The current Net Asset Value (NAV) of the PGIM India Healthcare Fund - Direct Growth plan is approximately ₹9.74 as of Jun 05, 2025.
The PGIM India Healthcare Fund - Direct Growth has an expense ratio of 0.66%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The PGIM India Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately ₹108 Crs crore as of Mar 31, 2025.
The PGIM India Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.06% |
Divi's Laboratories Ltd. | 7.75% |
Max Healthcare Institute Ltd. | 6.94% |
Dr. Reddy's Laboratories Ltd. | 6.04% |
Mankind Pharma Ltd. | 4.83% |
Aster DM Healthcare Ltd. | 4.78% |
Torrent Pharmaceuticals Ltd. | 3.9% |
Krishna Institute of Medical Sciences Ltd | 3.58% |
Ajanta Pharma Ltd. | 3.33% |
Abbott India Ltd. | 3.31% |
The PGIM India Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 85.47% |
Services | 4.52% |
Insurance | 2.86% |
Chemicals | 2.18% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in PGIM India Healthcare Fund is complete.
Redeeming your investments in PGIM India Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in PGIM India Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.